Literature DB >> 14551136

A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling.

Parham Minoo1, Maryam Mohsen Zadeh, Robert Rottapel, Jean-Jacques Lebrun, Suhad Ali.   

Abstract

SHP-1, an src homology 2 (SH2) domain containing protein tyrosine phosphatase, functions as a negative regulator of signaling downstream of cytokine receptors, receptor tyrosine kinases and receptor complexes of the immune system. Dephosphorylation of receptors and/or receptor-associated kinases has been described as the mechanism for the function of SHP-1. Here we demonstrate a novel mechanism by which SHP-1 down-regulates the Janus kinase-2 (Jak2)/signal transducer and activator of transcription-5 (Stat5) pathway downstream of the prolactin receptor (PRLR) and the erythropoietin receptor (EPOR) in a catalytic activity-independent manner. Structural/functional analysis of SHP-1 defined the C-terminal tyrosine residues (Y278, Y303, Y538, Y566) within growth factor receptor-bound protein 2 (Grb-2) binding motif to be responsible for delivering the inhibitory effects. Our results further indicate that these tyrosine residues, via recruitment of the adaptor protein Grb-2, are required for targeting the inhibitory protein suppressor of cytokine signaling-1 (SOCS-1) to Jak2 kinase. Finally, loss of SOCS-1 expression in SOCS-1(-/-) mouse embryonic fibroblast (MEF) cells led to attenuation in SHP-1 function to down-regulate PRL-induced Stat5 activation. All together, our results indicate that SHP-1 inhibits PRLR and EPOR signaling by recruitment and targeting of SOCS-1 to Jak2, highlighting a new mechanism of SHP-1 regulation of cytokine-receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551136     DOI: 10.1182/blood-2003-07-2617

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2007-11       Impact factor: 2.303

2.  Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

Authors:  Wenbin Xiao; Hong Hong; Yuko Kawakami; Clifford A Lowell; Toshiaki Kawakami
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

3.  A robust error model for iTRAQ quantification reveals divergent signaling between oncogenic FLT3 mutants in acute myeloid leukemia.

Authors:  Yi Zhang; Manor Askenazi; Jingrui Jiang; C John Luckey; James D Griffin; Jarrod A Marto
Journal:  Mol Cell Proteomics       Date:  2009-12-17       Impact factor: 5.911

Review 4.  Fine-tuning T cell receptor signaling to control T cell development.

Authors:  Guo Fu; Vasily Rybakin; Joanna Brzostek; Wolfgang Paster; Oreste Acuto; Nicholas R J Gascoigne
Journal:  Trends Immunol       Date:  2014-06-17       Impact factor: 16.687

5.  Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis.

Authors:  Scott B Ficarro; Yi Zhang; Marlene J Carrasco-Alfonso; Brijesh Garg; Guillaume Adelmant; James T Webber; C John Luckey; Jarrod A Marto
Journal:  Mol Cell Proteomics       Date:  2011-07-25       Impact factor: 5.911

6.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

7.  Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Anamika Pradeep; Melanie Ufkin; Jonathan D Licht; Don M Wojchowski
Journal:  Blood       Date:  2012-04-16       Impact factor: 22.113

8.  STAT5 activation is critical for the transformation mediated by myeloproliferative disorder-associated JAK2 V617F mutant.

Authors:  Megumi Funakoshi-Tago; Kenji Tago; Miyuki Abe; Yoshiko Sonoda; Tadashi Kasahara
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

9.  The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells.

Authors:  Thomas Bakken; Meilan He; Mark L Cannon
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

10.  The benzoxathiolone LYR-71 down-regulates interferon-gamma-inducible pro-inflammatory genes by uncoupling tyrosine phosphorylation of STAT-1 in macrophages.

Authors:  E-Y Chung; B-H Kim; I-J Lee; E Roh; S-J Oh; J-A Kwak; Y-R Lee; B Ahn; S-Y Nam; S-B Han; Y Kim
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.